One of our PDX models

News Date: 
12 July 2018

A recent paper from the Swinnen Lab, published in Nature Communications, showed that persistent SREBP-1-dependent lipogenesis is a key mediator of resistance to BRAF-targeted therapy in melanoma. The validation of these results was performed in collaboration with TRACE in one of our patient-derived melanoma xenograft models!

Trace PDX models

Search in our online database to find a relevant model that fits into your research pipeline. For more advice, contact us